Semiconductor industry breaking news. TSMC plans to adopt ASML's high numerical aperture technology in advanced process mass production starting in 2030. Apple and Kioxia sign long-term NAND supply agreement, possibly with no price cap. Samsung plans to apply high numerical aperture EUV to the mass production of DRAM by 2028. INTEL announced that it has processed more than 1 million 300mm wafers using its High Numerical Aperture Extreme Ultraviolet (High-NA EUV) lithography equipment. ASML pushes forward with upgrades to its next-generation lithography machines, targeting the large data center chip market. Malaysia is considering using Huawei's Ascend 910C processor to build a $494 million sovereign AI project. Novo Nordisk Foundation will invest $62 million to build a quantum chip factory in Denmark. Samsung's Taylor factory will begin trial production of 2nm chips at the end of September 2026. All capacity is currently booked, with an initial monthly capacity of 50,000 wafers.

Novo Nordisk Foundation to invest DKK 400m in quantum chip factory The Novo Nordisk Foundation is investing in a new factory in Copenhagen that will develop and manufacture quantum chips. The initial investment is expected to be DK 400m. MARKETWIRE 4 September 2026at 10:45

Novo Nordisk's Foundation is building a quantum chip factory in Copenhagen. The Novo Nordisk Foundation is building a $62 million quantum chip factory in Copenhagen, called Quantum Foundry Copenhagen, set to open around 2027. It's part of a broader DKK 2.9 billion quantum push meant to give Denmark a fault-tolerant quantum computer by 2034 and give Europe its own quantum chip supply chain. The foundation behind Novo Nordisk is putting new obesity-drug wealth into a 5,300 square meter quantum chip plant in Copenhagen. Europe says it wants chip sovereignty. This is what writing the check looks like. The Novo Nordisk Foundation and Quantum Foundry Copenhagen announced on September 4 that they plan to open a new quantum chip fabrication facility in Copenhagen in 2027. The plant will handle nanofabrication of quantum materials, testing, chip assembly and packaging, with ultra-high-vacuum manufacturing capability built into the same 5,300 square meter site. That's rare. According to the announcement carried by ADVFN, the foundry plans to offer wafer fabrication to quantum technology vendors globally on commercial terms. If you're building quantum hardware in Europe, that is the useful part. A strong research paper is nice. A place that can actually make the chip is better. Peter Krogstrup, CEO of Quantum Foundry Copenhagen, said the goal is to become a world-leading quantum chip manufacturer supplying Europe with advanced quantum computing processors and helping quantum companies scale production. That's not a modest line from a company owned by a foundation better known for diabetes and obesity science. But it tells you where the Novo Nordisk Foundation thinks the bottleneck sits. Adobe named Anil Chakravarthy, a former Informatica CEO, as its next president and CEO effective December 1, succeeding Shantanu Narayen after 19 years. The move puts an enterprise-software veteran in charge of defending Adobe's creative software dominance against Figma, Canva and AI-native rivals. - adobe hires new CEO to compete with Figma - Anil Chakravarthy becomes Adobe president and CEO December The money comes from a very unusual place. Novo Holdings, which is wholly owned by the Novo Nordisk Foundation, held 28.1% of Novo Nordisk's share capital and 77.3% of its votes at the end of 2025, according to the foundation's own ownership figures. Novo Nordisk's Ozempic and Wegovy made the Danish drugmaker one of Europe's most valuable companies. Now some of the wealth around that structure is being pushed into quantum hardware. This isn't the foundation's first move. It has committed more than DKK 2.9 billion, about EUR 390 million, to quantum technology, including the Novo Nordisk Foundation Quantum Computing Programme at the Niels Bohr Institute at the University of Copenhagen. That programme started in 2022 with a DKK 1.5 billion grant and has a hard target: Denmark's first fully functional, fault-tolerant quantum computer before 2034. The lab needs a factory. Europe doesn't lack quantum physicists. Denmark alone has the Niels Bohr Institute, DTU, Aarhus University and a growing group of quantum companies around Copenhagen. The weaker point is industrial scale-up, the expensive middle ground between research hardware and repeatable manufacturing. That's where the politicians come in. Henna Virkkunen, the European Commission executive vice president for technological sovereignty, security and democracy, tied the Copenhagen project directly to the European Chips Act, the Quantum Europe Strategy and the forthcoming Quantum Act. Martin Lidegaard, Denmark's minister of business and competitiveness, put the same point in plainer terms, saying technological breakthroughs matter when new knowledge becomes value for society and business. That is the gap Quantum Foundry Copenhagen is trying to close. A university group can prove a device works. A startup can raise enough to build a prototype. Neither automatically gets you a dedicated fabrication line for quantum processors, especially when the equipment has to deal with material purity and packaging demands that standard chip manufacturing doesn't simply solve for you. Lene Oddershede, chief scientific officer at the Novo Nordisk Foundation, said Europe shouldn't repeat the old pattern where basic science is strong on the continent but industrial platforms and global champions emerge somewhere else. She's right to be blunt about it. Europe has watched that movie before in semiconductors and consumer internet platforms. Then it watched it again in cloud computing. It didn't like the ending either time. Mark Zuckerberg personally lobbied President Trump against a proposed FINRA-style national AI regulator during a private call the week of August 17, 2026. The plan, championed by Google DeepMind's Demis Hassabis, remains under White House consideration despite Zuckerberg's objections, marking the second time this year he's helped reshape federal... - how Zuckerberg lobbied Trump to block AI regulator - Zuckerberg's call with Trump about national AI regulation A long bet with real money. Frankly, the pairing still looks odd on paper: obesity-drug wealth funding quantum chip equipment. But it also makes sense once you look at the time frame. Quantum hardware is hard, slow and expensive. Venture capital often wants a faster route to revenue than a fabrication plant can offer. Governments can announce strategies for years before steel and cleanroom tools show up. A foundation can behave differently. The Novo Nordisk Foundation was established in 1924 and says its mission is to support health and scientific purposes - sustainability included. It doesn't have to explain quarterly earnings in the same way a listed company does. That gives it room to fund infrastructure that may take a decade to prove itself. The risk is real. Quantum computing still has to show broad commercial usefulness beyond narrow demonstrations, and Novo Nordisk's own shares have come under pressure as obesity-drug competition has grown tougher. The fortune behind this push isn't a law of nature. It depends on a drugmaker still defending a market that Eli Lilly and others want badly. Still, this is a serious check attached to a serious date. Quantum Foundry Copenhagen is expected to open in 2027, and the foundation's bigger quantum programme is aiming at a fault-tolerant machine before 2034. Those dates give you the right way to judge the project. Not by whether Europe sounds ambitious this week, but by whether Copenhagen can turn a 5,300 square meter plant into chips that quantum companies actually buy. Founder discussion. No replies yet. Start the discussion. Judith Murphy is a financial journalist and market analyst covering AI, technology stocks, and emerging market trends. She has contributed to multiple financial publications and brings a data-driven approach to her coverage of the technology sector and its impact on global markets.